Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. L. Keohan, J. A. Morgan, D. R. D’Adamo, D. Harmon, J. E. Butrynski, A. J. Wagner, G. K. Schwartz, R. G. Maki, G. D. Demetri, S. George
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2249540046